Building a company in a highly regulated industry requires balancing growth, compliance, and mission-driven impact. Keith Kurlander, Co-Founder of the Integrative Psychiatry Institute, discusses his journey after spending years helping the organization scale while navigating the complex landscape of mental health regulations and emerging treatments on the latest episode of Business Trends Today.
Founded seven years ago by Kurlander and a psychiatrist co-founder, the Integrative Psychiatry Institute focuses on training licensed professionals in integrative psychiatry and psychedelic therapies, including ketamine treatment. The organization has trained more than 10,000 professionals, establishing itself as one of the largest providers in the field.
"Tenacity of both of us, the co-founders, and just our mission behind it, it was driving that tenacity."
Scaling the business involved addressing common challenges such as team building while managing the dynamics of a mission-driven, family-like company culture. Regulatory adaptation has been another critical factor, particularly as the institute expanded its psychedelic therapy training. Regulations for these therapies remain in flux, and the organization has worked to align its programs with evolving state and federal guidelines while maintaining medical ethics standards.
The institute focuses on training healthcare providers rather than working directly with patients, emphasizing education in emerging treatments. Ketamine therapy, a prescription-based treatment, has been central to the institute’s offerings. Adoption of psychedelic therapies is still in the early stages, but growing research and state-level measures are contributing to increased awareness and legitimacy of these approaches.
Key factors in the institute’s growth include tenacity, adaptability, and a mission-driven approach. Kurlander emphasizes the importance of knowing when to pivot, maintaining focus on core goals, and leading by example. The organization has also explored ways to make treatments accessible for populations such as veterans, particularly those struggling with treatment-resistant depression, while waiting for broader FDA approval of these therapies.
For entrepreneurs in mission-driven and regulated industries, Kurlander highlights persistence and confidence in one’s vision as essential for overcoming obstacles and achieving meaningful impact.
ASBN, from startup to success, we are your go-to resource for small business news, expert advice, information, and event coverage.
